Patient Assistance Programs

The Medicines Company Patient Assistance Program currently provides ANGIOMAX® (bivalirudin) for Injection and ORBACTIV® (oritavancin) for Injection at no cost to qualified patients who are not insured through private insurance or government-funded healthcare programs, e.g. Medicare or Medicaid. Healthcare providers can submit an application on behalf of the patient.  Please continue to check back on this web page for updates regarding The Medicines Company Patient Assistance Programs.

While The Medicines Company will make every effort to grant aid for requests that satisfy the eligibility criteria, these programs are limited to available resources and may be discontinued or revised at any time. If you have any additional questions, please call the hotlines listed on the right.